Introduction
Numerous materials have been used for bone substitution ever since plaster of paris was tried for bone repair in the 19'h century. In modern-day orthopedic surgery, metals (such as stainless steel and titanium alloy) and ceramics (such as alumina and toughened zirconia) are common in a variety of implants and devices. However, these materials, having been developed originally for other purposes rather than medical applications, are considerably stiffer than human bone. The modulus mismatch between an implant material and the host tissue can cause bone to resorb at the bone-implant interface, which leads to implant instability and hence its eventual failure [ 11. A long-lasting bone replacement requires the establishment of a stable bone-implant interface, which necessitates the careful matching of the mechanical behavior as well as mechanical Cortical (or compact) bone as a material is anisotropic with osteons (also known as "Haversian systems") being oriented parallel to the long axis of the bone and interspersed in regions of non-oriented bone (Figure 8 -2). Each osteon (about 100 to 300 |im in diameter) has a central Haversian canal (20 to 40 |im in diameter) containing a blood vessel, which supplies the elements required for bone remodeling. The Haversian canal is surrounded by 4 to 20 concentrically arranged lamellae with each lamella being 3 to 7 | Lim thick. Each adjacent lamellar layer has a different orientation of collagen fibers. Circumscribing the outermost concentric lamella of the osteon is a narrow zone known as cement line, which contains calcified mucopolysaccharides and is devoid of collagen. The cement line is 1 to 2 \im thick and is the weakest part of bone. The densely packed concentric lamellae in osteons are composed of two major components: fibrous collagen (which is a natural polymer) and bone mineral. The mineral crystallites that human bone contains are structurally calcium-deficient, carbonate-substituted hydroxyapatite. They are usually referred to as bone apatite, which normally has dimensions of 5 x 5 x 50 nm with a rod-like (or sometimes plate-like) habit and is embedded in collagen fibers. In mature bone, bone apatite occupies about 50 percent of the total volume. The precise microstructural organization of bone is a function of age and varies between different bones and between different locations of the same bone. Two levels of composite structure are considered when developing bone substitutes. First, the bone apatite reinforced collagen forming individual lamella (on the nanometer to micrometer scale) and, second, the osteon reinforced interstitial bone (on the micrometer to millimeter scale). It is the apatite-collagen composite at the microscopic level that provides the basis for producing bioceramic-polymer composites for bone replacement. The mechanical behavior of bone may be investigated by assessing whole bones in vivo. But the results obtained can be difficult to interpret due to irregular shapes of bones and the organizational hierarchy in bones. Normally, mechanical properties of bone (cortical or cancellous) are determined in vitro using standard or miniature specimens that conform to various standards originally designed for testing conventional materials such as metals and plastics. The conditions required to prepare and test dead bone specimens in order to gain meaningful results representative of living bone have been well established. It is very important to maintain water content of bone for mechanical assessment as the behavior of bone in the "wet" condition significantly differs from that of bone in a dry state [6] . Under the quasi-static testing condition, a tensile test of "wet" cortical bone at ambient temperature gives a stress-strain curve exhibiting a small viscoelastic component and culminating in brittle fracture at a total strain of 0.5-3.0 percent. As a result of orientation, location and age, cortical bone has a range of associated properties rather than a unique set of values (Table 8-1 ). Young's modulus of cortical bone therefore ranges between 7 and 30 GPa. It has been found that Young's modulus of cortical bone increases with an increase in the mineral content of bone [7] . Microhardness has been shown to be strongly related to Young's modulus for bone . Therefore, microhardness is a good predicator of Young's modulus of bone. It can also be seen from Table 8-1 that bone is significantly less stiff than the various alloys and ceramics currently utilized as prosthetic materials, but is stiffer than all biomedical polymers. Cortical bone fractures in a brittle fashion, with the ultimate tensile strength being 50 to 150 MPa. It is also known that fracture toughness -which is an important parameter for brittle solids -of bone is considerably lower than those of metallic implant materials. The structure and properties of cancellous (or spongy) bone are also well understood and documented [8] . Treating bone as a nanometer-scale composite, the mechanical behavior of bone may be explained using a simple composite model (Figure 8-4 ). Brittle apatite acts as a stiffening phase in bone, and ductile collagen provides a tough matrix. Consequently the tensile behavior of bone exhibits the combinational effect of these two major constituents of bone. A good understanding of the structure and properties of bone yields two-fold benefits. First, it gives good insight into the structural features of bone. Second, it provides the property range for approximating mechanical compatibility that is required of a bone analogue material for an exact structural replacement of bone with a stabilized bone-implant interface. It is important to bear in mind, however, that bone is unlike any engineering material in that it can alter its properties and configuration in response to changes in mechanical demand. 
Bioceramics and Biopolymers
Some ceramics and polymers have been used as hard tissue replacement materials for several decades now. Quite a few of these materials have achieved clinical success due to their distinctive characteristics. Several materials in these two categories can be combined to form composites for various medical applications.
Bioactive Ceramics
Ceramics for medical uses have come into prominence over the last two decades. With the modern and now widely accepted definition, the group of materials that are termed "bioceramics" includes ceramics, glasses, and glass-ceramics which are used to repair and reconstruct diseased, damaged, or "worn out" parts of the body. now. The interest in one particular group member, hydroxyapatite (HA), arises from its similarity to bone apatite (a biological apatite) -the major component of the inorganic phase of bone, which plays a key role in the calcification and resorption processes of bone.
Biological apatites constitute the mineral phase of calcified tissues such as bone, dentin, and enamel in the body and also some pathological calcifications. The general chemical formula for biological apatites is (Ca, M)10(PO4, C03, Y)6(OH, F, C1)2, where M represents metallic elements such as Na, K and Mg, Y represents functional groups such as acid phosphate, sulfate, etc. As compared to synthetic HA with the chemical formula of Calo(P04)6(0H)2, substitution in biological apatites by the carbonate group for the phosphate group takes place in a coupled manner, i.e., C0: -for PO: -while Na' for Ca2+. Biological apatites are usually calcium-deficient as a result of various substitutions in regular HA lattice points.
HA is the most commonly used calcium phosphate in the medical field as it possesses excellent biocompatibility and is osteoconductive. Its production and properties have been well documented [ 10,113. HA in the particulate form can be produced using a variety of methods. Characteristics of HA powders have significant effects on the subsequent products -where HA can be in the form of dense or porous structure, in coatings, or in composites. The production of HA powder generally falls into three categories: wet method, dry method, and hydrothermal method. The wet method can be used for the mass production of crystalline HA or non-crystalline calcium phosphate powder. One process with the wet method involves a neutral reaction of acid and alkaline solutions . The reaction temperature, reactant concentrations, and other production parameters should be carefully controlled in order to obtain high-purity, good-quality HA powder [ 121. Particle size, particle size distribution, and particle morphology of HA powders must be optimized for their use as the secondary, bioactive phase in various composites.
HA has been used clinically on its own as a bioactive material in the form of powder, porous structure, or dense body. The successful utilization of HA as an implant material should be in the first place attributed to its good biocompatibility -which is a perceived advantage of being a material similar to the mineral phase in bone and teeth when replacing these tissues.
Another attractive member of the calcium phosphate family for medical applications is tricalcium phosphate (TCP). The chemical formula of TCP is Ca3(PO4)2, and TCP has four polymorphs: a , P, y, and super-a. The y polymorph is a high-pressure phase and the super-a polymorph is observed at temperatures above approximately 1500°C. Therefore the most frequently encountered TCP polymorphs in the field of bioceramics are a -and P-TCP. TCP is a bioresorbable ceramic, and the dissolution rate increases in the following order:
(1) HA < P-TCP < a-TCP 
Biocompatible Polymers
Polymers are long-chain molecules that consist of small repeating units ( i e . , "mers"). There are a wide variety of polymers including natural materials (such as cellulose and collagen) and synthetic materials (such as polyethylene and poly(methy1 methacrylate) (i.e., PMMA)). Medical use of synthetic polymers has a long history. The success of polymers in medicine can be exemplified by the applications of PMMA and ultra high molecular weight polyethylene (UHMWPE) in total hip replacement. The great number of currently available synthetic polymers makes the selection of a suitable polymer for a particular biomedical application a difficult task. However, among all properties required for an application, biocompatibility of the polymer with tissues and biological fluids is always the foremost consideration for all candidate materials. On the basis of years of laboratory experimentation and clinical investigation, the following synthetic polymers are considered "biocompatible" [ 14,151: polyethylene (PE), polypropylene (PP), polyurethane (PU), polytetrafluoroethylene (PTFE), poly(viny1 chloride) (PVC), polyamides (PA), poly(methy1 methacrylate) (PMMA), polyacetal, polycarbonate (PC), poly(ethy1ene terephthalate) (PET), polyetheretherketone (PEEK), and polysulfone (PSU). These polymers are also considered "biostable" in the body and have found wide applications in the medical field, ranging from PTFE vascular grafts to UHMWPE acetabular cups.
Among all biostable polymers, polyethylene (PE) occupies a prominent position for medical devices. PE is a synthetic polymer and has the chemical formula of (CH2CH2),,. It is produced from ethylene through various processes [ 161. Depending on the manufacturing process used, different polyethylenes are made: low density polyethylene (LDPE), linear low density polyethylene (LLDPE), high density polyethylene (HDPE), cross-linked polyethylene (XLPE), and ultra high molecular weight polyethylene (UHMWPE). The properties of these polyethylenes depend on the length and degree of branching of the polyolefin chains. Generally the higher the degree of branching, the lower the density of the solid. The density of polyethylenes ranges from 0.92 to 0.97 g/cm3 [16, 17] . It is HDPE and UHMWPE that have found extensive applications in the medical field.
UHMWPE is a linear polyethylene that has an extremely high average molecular weight (Mw). Its M, is approximately 4~1 0~ g/mol, which is an order of magnitude greater than that of HDPE. It has outstanding resistance to wear and abrasion and low coefficient of friction. Due to its wear resistance and low friction characteristics when coupled with metals such as Co-Cr alloys and stainless steel, it has been used for acetabular cups in total hip prostheses for over thirty years now.
HDPE consists of molecules that are essentially linear, typically with fewer than one branch per 200 carbon atoms in the backbone. The linearity of polymer chains permits the development of high degrees of crystallinity which results in the highest modulus and the lowest permeability of all classes of polyethylenes. HDPE can thus have Young's modulus of up to 1 GPa, tensile strength above 20 MPa and elongation at break greater than 100 percent. HDPE has already been in use in tubing for drains and catheters due to its excellent toughness and its resistance to fats and oils. Furthermore, HDPE, having high content of particulate filler, can still be melt processed using current extrusion and molding technology, thereby providing the option of mass production of implants at reasonable manufacturing costs. The advantage that HDPE is a linear polymer with very few branches is very important. This is because when advanced polymer processing technology such as hydrostatic extrusion is used, polyethylene chains will be aligned in the extrusion direction and hence high modulus and high strength materials can be produced.
If biodegradation is desired of implants, biocompatible and biodegradable polymers can be used. These polymers include poly(1actic acid) (PLA), poly(g1ycolic acid) (PGA), poly(~-caprolactone) (PCL), polyhydroxybutyrate (PHB), and a few other polymers [ 181. It must be borne in mind that during the selection of a biodegradable polymer, apart from other required properties, the degradation rate of the material should be matched with the growth rate of the new tissue. 
Replacement Hydroxyapatite Reinforced Polyethylene Composites for Bone
The success that metals, polymers, and ceramics have achieved in tissue substitution should not hinder the progress in pursuing better and smarter materials for implants and medical devices. And indeed the last twenty years have witnessed a rapid pace in the development of new biomaterials.
Combining Hydroxyapatite and Polyethylene for Bioactive Bone Analogues
As bone is an apatite-collagen composite material at the ultra-structural level, a polymer matrix composite containing a particulate, bioactive component appears a natural choice for substituting cortical bone. Bonfield et al. pioneered the use of hydroxyapatite (HA) particles as the bioactive and strengthening phase in polymers to produce bone analogues [ 191. HA closely resembles bone apatite and exhibits excellent bioactivity. Polyethylene (PE) is a proven biocompatible polymer and widely used in orthopedics. It is therefore natural to combine these two materials to produce a composite that mimics the structure and matches the mechanical properties of cortical bone. The ductile polyethylene allows incorporation of relatively high volume percentages of HA particles in the polymer matrix, which is essential for obtaining bioactivity of the composite. With good bioactivity of the composite due to the presence of particulate HA, a strong bond should be formed between implants made of the composite and the surrounding tissue. As no other materials are used, all components of the composite are biocompatible and hence the composite should also be biocompatible.
Manu facture of Hydroxyapatitelpoly ethy lene Composites
HNHDPE composites containing up to 45 vol% (i.e., 73 wt%) of HA can be routinely made through standardized procedures [20,2 11. The process for manufacturing HA/HDPE composites is outlined in Figure 8 -6.
Both commercially available HA powders and particulate HA produced in-house have been used to produce HNHDPE composites. Either a twin screw extruder [20] or an internal mixer [21] was used for compounding the materials efficiently. Compounding using two-roll mills appeared to be unsuitable due to their inability to cope with composites of high HA volume fractions and also polymer degradation. Powdering of compounded materials usually took place in a centrifugal mill at below -100°C. Compression or injection molding could produce bulk materials for prostheses or even some small medical devices. Composite plates as thick as 20 mm could be made by compression molding 8-1 1
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Rheological studies revealed that the incorporation of particulate HA into HDPE resulted in an increase in the viscosity of composites at their processing temperatures [22, 23] . The presence of HA particles restricted molecular mobility of HDPE under shear and hence resulted in higher viscosity. This increase in viscosity was more pronounced at low shear rates (Figure 8-7) . When the shear rate was increased, the viscosity of HA/HDPE composites approached that of the unfilled HDPE. Both HDPE and HNHDPE composites showed pronounced shear thinning behavior. HA/HDPE composites at their processing temperatures exhibited discontinuity with a varying shear rate. As the HA content in the composite increased, the shear rates at which discontinuity occurred were reduced. The die swell ratio of HA/HDPE composite was reduced as the HA content was increased. It is possible that the presence of HA
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particles in the polymer matrix reduced the degree of recoiling of the HDPE molecular chains and hence led to the reduction in swelling of composite. Analysis of rheological behavior of HA/HDPE composites is important for optimizing composite processing conditions and for producing high-quality, net-shape (or near net-shape) medical devices.
Structure of Hydroxyapatite/polyethylene Composites
SEM examination of polished HA/HDPE surfaces showed that after the compounding process, HA particles were well dispersed, exhibiting a homogeneous distribution in the polymer matrix (Figure 8-8 ). Subsequent composite processing by compression molding preserved these characteristics. This uniform distribution of HA particles in composites is essential for mechanical as well as biological performance of implants. Using the image analysis technique and stereology, it was possible to calculate the average volume diameter of HA particles in composites from SEM micrographs (ie., from two-dimensional images to three-dimensional projections).
The calculations indicated that the high shear forces generated during the compounding process broke up HA particle agglomerates into unit particles in the polymer matrix [24] . The average volume diameter of HA particles in compounded HNHDPE was nearly the same as the mean particle size of HA powder used for producing the composites (Table 8 -2). SEM examination of tensile fracture surfaces suggested that in the composites, there was only mechanical bond between HA particles and HDPE matrix (Figure 8-9 ) due to the shrinkage of HDPE around individual HA particles during thermal processing [20, 25] . It was found that compounding caused slight decreases in the weight average molecular mass (M,) of HDPE, with the decrease being dependent on HA volume fraction [25] . Further thermal processing by compression or injection molding also reduced M,. Differential scanning calorimetry (DSC) results indicated that the addition of HA particles caused decreases in the degree of crystallinity of HDPE, where composites of higher HA contents had lower degrees of crystallinity for the polymer matrix [21] .
Thermogravimetric analysis (TGA) was used to determine the real HA content in HA/HDPE composites (Figure 8-10 ). Calculations made from the TGA curves showed that the difference between the actual mass percentages of HA in the composites produced and the "Rule of Mixtures (ROM)" values was negligible. Hence the intended compositions had been achieved (Table 8- 
Mechanical Properties of Hydroxyapatite/polyethylene Composites
By varying the amount of HA in the composite, a range of mechanical properties of the material and biological responses to the material could be obtained. The incorporation of HA in HDPE evidently stiffened the composite (Figure 8-1 1 ). The particle morphology and average particle size of HA were found to affect mechanical properties of HA/HDPE composites [26] . HA/HDPE with 45 vol% of HA possessed a Young's modulus value of 5.54 GPa, approaching the lower bound for cortical bone (Table 8-4). HA/HDPE composites containing around 40 vol% appeared to be suitable for clinical use in bone substitution. But the actual composite to be used depends on the nature of bone being replaced and the anticipated physiological load. Using an instrumented falling weight impact tester, it was shown that for HA/HDPE composites an increase in HA content produced a decrease in impact energy for fracture [27] . However, the HA content seemed to have little effect on the maximum impact force for fracture as this force was at nearly the same level for composites of all compositions. Under this type of impact condition, the failure of composites containing various amounts of HA was classified as "brittle", since there were no evidences of gross plastic deformation when compared to the rupture of the matrix polymer itself.
Microhardness of HA/HDPE composites increased with an increase in HA content [7, 21] . However for a given volume fraction of the ceramic phase (either HA or bone apatite), the hardness of HA/HDPE composites was considerably lower than that of the native tissue. This could be due to the different particle size, the distribution of ceramic phase, and the way in which ceramic particles are bonded to the matrix.
Dynamic properties and the damping capability of HA/HDPE composites were also studied in detail [21, 25, 28] . Dynamic mechanical analysis (DMA) results showed that the storage modulus of the composites increased with increase in HA content and decreased with increase in temperature ( Figure  8-1 2) . Unlike storage modulus which decreased monotonically with increase in temperature, the loss modulus of the composites decreased when the temperature rose from -100°C to -25°C. It then increased to peak at around 4OoC, with a subsequent decrease towards higher temperatures. It was also shown that the addition of HA particles into HDPE reduced the damping The creep behavior of HA/HDPE composites was investigated using a three-station tensile creep machine [29-3 I] . The inclusion of HA particles in HDPE improved the short-term creep resistance when specimens were subjected to similar stresses. Hence an increase in the HA volume fraction increased creep resistance (Figure 8-14) . The increase of creep resistance is associated with the increase in moduli of the composites. However creep failure of composites could occur at prolonged times due to debonding at the HA-HDPE interface. Immersion in Ringer's solution reduced the creep resistance of HA/HDPE composites. This effect was due to the penetration of fluid into the composites. The decrease in creep resistance and hence the increase in the amount of fluid penetration were found to be a function of HA volume fraction [30] .
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Lg t ( 4 Figure 8-14 Creep strain versus time for HNHDPE composite loaded at different stress levels in Ringer's solution (HDPE at 2 MPa, 20%HA/HDPE at 4 MPa, 40%HNHDPE at 8 MPa) [29] Biaxial (ie., axial and torsional) fatigue tests were conducted using standard fatigue specimens for HA/HDPE composites [32] . The ultimate shear strength of HDPE and HA/HDPE composite with 20 vol% of HA was determined to be 17.12 MPa and 17.46 MPa respectively. A fixed axial component of 50 percent of ultimate tensile strength (UTS) with the torsional component varying from zero percent to 50 percent of ultimate shear strength (USS) was used for fatigue tests. Generally the fatigue life of HDPE and that of the composite were reduced when shear stress increased in the biaxial stress condition (Figure  8-15 ). The addition of particulate HA in HDPE led to shorter fatigue life in low shear stress conditions. HDPE specimens did not fail after one million fatigue cycles with shear stress levels being zero percent and 12.5 percent of USS, whereas composite specimens failed at finite numbers of cycles under the same stress conditions. In high shear stress conditions, the effects of shear stress became dominant and the fatigue lives of both HDPE and HA/HDPE were about the same.
Tribological properties (i. e., coefficient of friction, wear rate, and lubrication in the presence of proteins) of HDPE and HNHDPE composite were evaluated against duplex stainless steel under dry and lubricated conditions [33] .
Lubricants included distilled water and aqueous solutions of proteins (egg albumen or glucose). It was found that HA/HDPE composite had lower coefficients of friction than HDPE under certain conditions. However the addition of HA beyond 10 vol% deteriorated the tribological properties of HA/HDPE composite by forming an abrasive slurry of HA in the lubricants. Both egg albumen and glucose were shown to be corrosive to steel and adversely reactive for HDPE and HA/HDPE composite. HA/HDPE composite appeared unsuitable for implants with articulating surfaces. 
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In Vitro and In Vivo Assessments
For implant materials, it is essential to demonstrate that they are biocompatible with host tissues. It is well established now that the response of the body to an implant is to produce a fibrous capsule which may be remodeled with time. If the material is toxic, the fibrous capsule will increase in thickness; if the material is inert, the fibrous capsule will be of constant thickness [I] . However with a bioactive implant material such as hydroxyapatite, which releases calcium and phosphate ions from its surfaces and encourages the deposition of an apatite layer on the implant surface, the fibrous capsule will thin and disappear. When a bone analogue material is implanted into the body, the response to the material depends on a combination of responses to the constituents of the composite.
The biological performance of implant materials can be evaluated by in vitro tests using simulated body fluid or cell cultures, or by in vivo assessments. In in vitro experiments using human osteoblast cell primary cultures, it was observed that the osteoblast cells attached to "islands" of HA in the composite and subsequently proliferated (Figure 8-1 6) , thus showing clearly the biocompatibility and bioactivity of HA/HDPE composite [34] . For in vivo experiments, following sterilization by y irradiation, machined pins (@ 2.4mmx5mm) of HA/HDPE composite were implanted in the lateral femoral condyle of adult New Zealand white rabbits [35] . It was demonstrated that cortical and cancellous bones responded positively to the presence of HA/HDPE implant by localized apposition adjacent to the implant surface. The implant was initially surrounded by a fibrous layer, which was in turn surrounded by a layer of new bone. With time the fibrous layer was locally replaced by newly formed bone, which created a strong bond between the natural bone and the implant. After six months' implantation, the areas of direct bone apposition -as measured from histological sections -had reached 40 percent of the implant surface. As the limb of rabbits was not immobilized during the in vivo tests, this favorable bone response to the HA/HDPE implant occurred during physiological loading. Such an observation indicated that the mechanical compatibility of the HA/HDPE composite with natural bone had resulted in the absence of significant relative movement at the bone-implant interface, thus encouraging bone growth around the implant. Ultra-microtomed specimens were also prepared for TEM examinations of the bone-implant interface [36]. At one month, the new bone was mainly seen adjacent to the interface where HA particles were present. At six months, the bone tissue was seen growing along the whole length of composite implant including exposed HA particles and polyethylene matrix. High-resolution TEM imaging revealed lattice fringes of bone apatite in bone and HA in HA/HDPE implant. The image of lattice planes at the bone-implant interface after three months' implantation is shown in Figure 8 -17. It exhibited continuity across the interface, thus indicating epitaxial growth of apatite crystals from the implant into new bone.
Clinical Applications
Since the late 1980s, subperiosteal orbital floor implants made from HA/HDPE composites have been used in the correction of volume deficient sockets and in orbital floor reconstruction following trauma [37, 38] . All the implants remained in position, and no infections or extrusions occurred. Clinical examination found the implants to feel stable. After six months' implantation computer tomography (CT) was unable to detect any gap between the implant and bone, implying at least partial integration of the implant with the orbital floor, which accounted for the marked implant stability (Figure 8-18 ). More recently middle ear implants were made from HA/HDPE composites, and satisfactory clinical results have been obtained [39] . 
8.4J Enhanced Hydroxyapatite/polyethylene Composites
HA/HDPE composites exhibit required bioactivity which promotes the formation of biological bond between bone and implants made of the composites. To improve mechanical properties of HA/HDPE composites for load bearing implant applications, hydrostatic extrusion of the composites was investigated [40] . It was found that higher extrusion ratios led to higher Young's modulus and tensile strength of HA/HDPE composites which are within the bounds for mechanical properties of cortical bone (Figure 8-20) . The fracture strain of HA/HDPE was also substantially increased by hydrostatic extrusion. Extruded HNHDPE containing 40 vol% of HA possessed a strain to fracture which was far greater than that of human cortical bone (9.4% versus 1-3%). Furthermore the bioactivity of the composites was retained after extrusion.
Therefore HA/HDPE which has been further processed via hydrostatic extrusion exhibits great potential for major load bearing applications. An alternative method to enhance mechanical properties of the composites, i.e., using chemical coupling for HA with HDPE, was also studied [41] . However only limited improvements in tensile strength and ductility were achieved, and Young's modulus was slightly decreased. It was observed that the chemical bond established between HA and HDPE delayed the dewetting and cavitation processes, but could not prevent interfacial debonding which caused eventual failure of the composites.
Using chopped high-modulus PE fibers as the matrix material for HA reinforced PE composites was also investigated [42] . Chopped PE fibers could provide a matrix with much higher modulus and strength values. It was found that the fiber morphology of the matrix had a positive contribution to the mechanical properties of the composites. However the uneven distribution of particulate HA in the composites of PE fiber matrix remains a major problem.
Other Bioceramic-Polymer Composites for Medical Applications
To establish a stronger bone-implant interface within a shorter period of time, glasses or ceramics that are more bioactive than HA can be used as the bioactive phase in the composites. Therefore using the same or similar manufacturing processes, bioactive composites such as Bioglass@/high-density polyethylene
[43] and A-W glass-ceramic/high-density polyethylene [44] have been developed for tissue substitution. These composites exhibited enhanced bioactivity (Figure 8-21 When a biodegradable polymer is used as matrix of the composite, a bioactive and biodegradable composite is developed. After implantation in the body, a biodegradable bone-substituting material will have gradual decreases in strength and stiffness over a clinically determined optimal period. As bone repairs itself, the external load will be transferred from the biodegrading implant to bone. This approach provides the best biomaterials solution to tissue replacement and regeneration, if requirements for the initial stiffness and strength and other short-term performance criteria can be met. To date, the bioactive and biodegradable composites developed include hydroxyapatite/poly(L-lactide) [ In recent years, tissue engineering as a multidisciplinary endeavor has shown promises in combating medical problems of tissue loss and organ failure. One of the key issues in tissue engineering is the development of suitable materials and scaffolds for seeding cells and for subsequent growth of tissues.
Efforts have been made to produce bioactive and biodegradable scaffolds for such purposes. There have been reports on scaffolds based on composites such as hydroxyapatite/poly(DL-lactic-co-glycolic acid) [59, 60] , hydroxyapatite/poly(caprolactone) [61] , hydroxyapatite/chitin and calcium phosphate/poly(L-lactic acid) [62] . Both bioactivity and biodegradability of these composite scaffolds are clearly shown in Figure The use of bioactive particles or short fibers in composites is not confined to the area of tissue replacement and tissue regeneration. The concept of bioactive composites has also been extended to other areas such as bone cement and dental materials. Investigations into bioactive bone cement started nearly twenty years ago, and work on hydroxyapatite/poly(methylmethacrylate) [63] , hydroxyapatite/poly(ethylmethacrylate) [64] , and tricalcium phosphate/poly (propylene fumarate) [65] has been reported. Research on bioactive dental composites has also been conducted [66, 67] .
Concluding Remarks
Most tissues in the human body are natural composite materials, and they serve as templates in the development of replacement materials. Over the last few decades, composites science and technology has matured and established itself as a new discipline. Great advances have been made in developing various composite materials to meet requirements firstly in the aerospace industry, then in the automotive industry and civil engineering sector, and more recently in the healthcare industry. Man-made composites have distinctive properties that their constituents do not possess. Very often, these properties are required to meet specific needs. Bioactive polymeric matrix composites have shown their efficacy and can find wide applications. However, to date, no one material can exactly match the structure and properties of any particular human tissue. Perhaps no material will do, bearing in mind that biological materials such as bone have the exceptional ability of self-repair. Nevertheless, materials scientists and engineers will certainly use their knowledge and expertise to invent new materials and devise viable systems to help improve the quality of life of people who unfortunately have diseased or damaged tissues. Man learns from nature, man may imitate nature, but man cannot beat nature.
The future development in tissue repair may also depend on research in the emerging field of tissue engineering. However the traditional approach in designing new materials for specific applications will still remain as an essential and viable means in the course of combating problems in the medical field.
